nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergotamine—ABCB1—Levothyroxine—hypothyroidism	0.175	0.28	CbGbCtD
Ergotamine—ABCB1—Liothyronine—hypothyroidism	0.175	0.28	CbGbCtD
Ergotamine—ABCB1—Liotrix—hypothyroidism	0.171	0.273	CbGbCtD
Ergotamine—CYP3A4—Levothyroxine—hypothyroidism	0.105	0.168	CbGbCtD
Ergotamine—HTR2A—cerebellar cortex—hypothyroidism	0.0144	0.0814	CbGeAlD
Ergotamine—Cyanosis—Liotrix—hypothyroidism	0.0104	0.133	CcSEcCtD
Ergotamine—CYP1A2—urine—hypothyroidism	0.00982	0.0553	CbGeAlD
Ergotamine—SLC6A2—nerve—hypothyroidism	0.00881	0.0496	CbGeAlD
Ergotamine—DRD2—nerve—hypothyroidism	0.00803	0.0452	CbGeAlD
Ergotamine—Hypertension—Liothyronine—hypothyroidism	0.00769	0.0981	CcSEcCtD
Ergotamine—HTR2A—urine—hypothyroidism	0.00767	0.0432	CbGeAlD
Ergotamine—CYP3A4—urine—hypothyroidism	0.0071	0.04	CbGeAlD
Ergotamine—Tachycardia—Liothyronine—hypothyroidism	0.0071	0.0905	CcSEcCtD
Ergotamine—HTR1E—female gonad—hypothyroidism	0.00602	0.0339	CbGeAlD
Ergotamine—HTR2A—nerve—hypothyroidism	0.0053	0.0298	CbGeAlD
Ergotamine—HTR1B—cardiovascular system—hypothyroidism	0.00386	0.0217	CbGeAlD
Ergotamine—HTR2B—adrenal cortex—hypothyroidism	0.00381	0.0215	CbGeAlD
Ergotamine—HTR1D—cardiovascular system—hypothyroidism	0.00373	0.021	CbGeAlD
Ergotamine—HTR2B—heart—hypothyroidism	0.00368	0.0207	CbGeAlD
Ergotamine—Hypoaesthesia—Liotrix—hypothyroidism	0.00368	0.0469	CcSEcCtD
Ergotamine—Tachycardia—Levothyroxine—hypothyroidism	0.00349	0.0445	CcSEcCtD
Ergotamine—Tachycardia—Dextrothyroxine—hypothyroidism	0.00349	0.0445	CcSEcCtD
Ergotamine—HTR2B—cardiovascular system—hypothyroidism	0.00347	0.0196	CbGeAlD
Ergotamine—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00325	0.0415	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00325	0.0415	CcSEcCtD
Ergotamine—HTR1A—cardiovascular system—hypothyroidism	0.00311	0.0175	CbGeAlD
Ergotamine—ADRA1A—heart—hypothyroidism	0.00304	0.0171	CbGeAlD
Ergotamine—ADRA1A—cardiovascular system—hypothyroidism	0.00287	0.0162	CbGeAlD
Ergotamine—SLC6A2—gonad—hypothyroidism	0.0028	0.0158	CbGeAlD
Ergotamine—Hypertension—Liotrix—hypothyroidism	0.00278	0.0355	CcSEcCtD
Ergotamine—HTR2B—adrenal gland—hypothyroidism	0.00275	0.0155	CbGeAlD
Ergotamine—HTR2B—blood—hypothyroidism	0.00275	0.0155	CbGeAlD
Ergotamine—HTR2B—thyroid gland—hypothyroidism	0.00265	0.0149	CbGeAlD
Ergotamine—Tachycardia—Liotrix—hypothyroidism	0.00256	0.0327	CcSEcCtD
Ergotamine—Asthenia—Levothyroxine—hypothyroidism	0.00256	0.0327	CcSEcCtD
Ergotamine—Asthenia—Dextrothyroxine—hypothyroidism	0.00256	0.0327	CcSEcCtD
Ergotamine—Pruritus—Levothyroxine—hypothyroidism	0.00253	0.0322	CcSEcCtD
Ergotamine—Pruritus—Dextrothyroxine—hypothyroidism	0.00253	0.0322	CcSEcCtD
Ergotamine—DRD2—pituitary gland—hypothyroidism	0.00249	0.014	CbGeAlD
Ergotamine—HTR1A—adrenal gland—hypothyroidism	0.00246	0.0139	CbGeAlD
Ergotamine—SLC6A2—adrenal gland—hypothyroidism	0.00244	0.0138	CbGeAlD
Ergotamine—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.00239	0.0305	CcSEcCtD
Ergotamine—Paraesthesia—Liotrix—hypothyroidism	0.00236	0.0301	CcSEcCtD
Ergotamine—ADRA2A—heart—hypothyroidism	0.00231	0.013	CbGeAlD
Ergotamine—Vomiting—Dextrothyroxine—hypothyroidism	0.00227	0.029	CcSEcCtD
Ergotamine—Vomiting—Levothyroxine—hypothyroidism	0.00227	0.029	CcSEcCtD
Ergotamine—ADRA1A—adrenal gland—hypothyroidism	0.00227	0.0128	CbGeAlD
Ergotamine—ADRA1A—blood—hypothyroidism	0.00227	0.0128	CbGeAlD
Ergotamine—Nausea—Dextrothyroxine—hypothyroidism	0.00212	0.0271	CcSEcCtD
Ergotamine—Nausea—Levothyroxine—hypothyroidism	0.00212	0.0271	CcSEcCtD
Ergotamine—SLC6A2—testis—hypothyroidism	0.00202	0.0114	CbGeAlD
Ergotamine—ADRA2A—gonad—hypothyroidism	0.00198	0.0112	CbGeAlD
Ergotamine—HTR2A—heart—hypothyroidism	0.00197	0.0111	CbGeAlD
Ergotamine—ADRA2A—pituitary gland—hypothyroidism	0.00193	0.0109	CbGeAlD
Ergotamine—Asthenia—Liotrix—hypothyroidism	0.00189	0.024	CcSEcCtD
Ergotamine—HTR1A—cerebellum—hypothyroidism	0.00188	0.0106	CbGeAlD
Ergotamine—CYP1A2—blood—hypothyroidism	0.00188	0.0106	CbGeAlD
Ergotamine—Pruritus—Liotrix—hypothyroidism	0.00186	0.0237	CcSEcCtD
Ergotamine—HTR2A—cardiovascular system—hypothyroidism	0.00186	0.0105	CbGeAlD
Ergotamine—DRD2—testis—hypothyroidism	0.00184	0.0104	CbGeAlD
Ergotamine—CYP1A2—thyroid gland—hypothyroidism	0.00181	0.0102	CbGeAlD
Ergotamine—ADRA1A—liver—hypothyroidism	0.00177	0.01	CbGeAlD
Ergotamine—ADRA1A—cerebellum—hypothyroidism	0.00173	0.00977	CbGeAlD
Ergotamine—ADRA2A—adrenal gland—hypothyroidism	0.00173	0.00972	CbGeAlD
Ergotamine—ADRA2A—blood—hypothyroidism	0.00173	0.00972	CbGeAlD
Ergotamine—DRD2—cerebellum—hypothyroidism	0.0017	0.00957	CbGeAlD
Ergotamine—HTR2A—gonad—hypothyroidism	0.00168	0.00949	CbGeAlD
Ergotamine—Vomiting—Liotrix—hypothyroidism	0.00167	0.0213	CcSEcCtD
Ergotamine—ADRA2A—thyroid gland—hypothyroidism	0.00167	0.00938	CbGeAlD
Ergotamine—HTR2A—pituitary gland—hypothyroidism	0.00164	0.00926	CbGeAlD
Ergotamine—ADRA2A—female gonad—hypothyroidism	0.00161	0.00907	CbGeAlD
Ergotamine—Nausea—Liotrix—hypothyroidism	0.00156	0.0199	CcSEcCtD
Ergotamine—HTR2A—adrenal gland—hypothyroidism	0.00147	0.00827	CbGeAlD
Ergotamine—CYP1A2—liver—hypothyroidism	0.00147	0.00827	CbGeAlD
Ergotamine—HTR2A—blood—hypothyroidism	0.00147	0.00827	CbGeAlD
Ergotamine—ADRA2A—testis—hypothyroidism	0.00143	0.00804	CbGeAlD
Ergotamine—CYP3A4—blood—hypothyroidism	0.00136	0.00765	CbGeAlD
Ergotamine—ABCB1—adrenal cortex—hypothyroidism	0.00133	0.00751	CbGeAlD
Ergotamine—ADRA2A—cerebellum—hypothyroidism	0.00132	0.00743	CbGeAlD
Ergotamine—ABCB1—heart—hypothyroidism	0.00129	0.00726	CbGeAlD
Ergotamine—ABCB1—cardiovascular system—hypothyroidism	0.00122	0.00685	CbGeAlD
Ergotamine—HTR2A—testis—hypothyroidism	0.00121	0.00684	CbGeAlD
Ergotamine—HTR2A—liver—hypothyroidism	0.00115	0.00646	CbGeAlD
Ergotamine—HTR2A—cerebellum—hypothyroidism	0.00112	0.00632	CbGeAlD
Ergotamine—ABCB1—gonad—hypothyroidism	0.0011	0.00622	CbGeAlD
Ergotamine—ABCB1—pituitary gland—hypothyroidism	0.00108	0.00607	CbGeAlD
Ergotamine—CYP3A4—liver—hypothyroidism	0.00106	0.00598	CbGeAlD
Ergotamine—ABCB1—adrenal gland—hypothyroidism	0.000962	0.00542	CbGeAlD
Ergotamine—ABCB1—blood—hypothyroidism	0.000961	0.00542	CbGeAlD
Ergotamine—ABCB1—thyroid gland—hypothyroidism	0.000928	0.00523	CbGeAlD
Ergotamine—ABCB1—female gonad—hypothyroidism	0.000897	0.00505	CbGeAlD
Ergotamine—ABCB1—testis—hypothyroidism	0.000795	0.00448	CbGeAlD
Ergotamine—ABCB1—liver—hypothyroidism	0.000752	0.00424	CbGeAlD
Ergotamine—ABCB1—cerebellum—hypothyroidism	0.000734	0.00414	CbGeAlD
Ergotamine—HTR1D—GPCR downstream signaling—AVP—hypothyroidism	0.000119	0.00101	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—TRH—hypothyroidism	0.000119	0.00101	CbGpPWpGaD
Ergotamine—HTR2A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000118	0.001	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—TSHB—hypothyroidism	0.000118	0.001	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—TSHR—hypothyroidism	0.000118	0.001	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—TSHB—hypothyroidism	0.000118	0.001	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—TSHR—hypothyroidism	0.000118	0.001	CbGpPWpGaD
Ergotamine—HTR1E—GPCR downstream signaling—POMC—hypothyroidism	0.000117	0.000989	CbGpPWpGaD
Ergotamine—HTR1B—GPCR downstream signaling—AVP—hypothyroidism	0.000116	0.000988	CbGpPWpGaD
Ergotamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000116	0.000983	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—TSHB—hypothyroidism	0.000116	0.000981	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—TSHR—hypothyroidism	0.000116	0.000981	CbGpPWpGaD
Ergotamine—ADRA2A—Hemostasis—VAV3—hypothyroidism	0.000114	0.000971	CbGpPWpGaD
Ergotamine—HTR2B—GPCR downstream signaling—VAV3—hypothyroidism	0.000114	0.000963	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—TPO—hypothyroidism	0.000113	0.000962	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—IYD—hypothyroidism	0.000113	0.00096	CbGpPWpGaD
Ergotamine—HTR1F—Signaling by GPCR—POMC—hypothyroidism	0.000112	0.000952	CbGpPWpGaD
Ergotamine—HTR1D—Signaling by GPCR—VAV3—hypothyroidism	0.000112	0.000951	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—PRL—hypothyroidism	0.000112	0.000949	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—TRH—hypothyroidism	0.000112	0.000948	CbGpPWpGaD
Ergotamine—HTR1B—Signaling by GPCR—VAV3—hypothyroidism	0.00011	0.000931	CbGpPWpGaD
Ergotamine—HTR2B—GPCR downstream signaling—AVP—hypothyroidism	0.000109	0.000928	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—CLTC—hypothyroidism	0.000109	0.000921	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—TSHB—hypothyroidism	0.000108	0.000918	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—TSHR—hypothyroidism	0.000108	0.000918	CbGpPWpGaD
Ergotamine—ADRA2B—GPCR ligand binding—POMC—hypothyroidism	0.000108	0.000917	CbGpPWpGaD
Ergotamine—HTR1D—Signaling by GPCR—AVP—hypothyroidism	0.000108	0.000916	CbGpPWpGaD
Ergotamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000108	0.000913	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—TSHB—hypothyroidism	0.000107	0.000911	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—TSHR—hypothyroidism	0.000107	0.000911	CbGpPWpGaD
Ergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.000106	0.000902	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—TSHB—hypothyroidism	0.000106	0.000899	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—TSHR—hypothyroidism	0.000106	0.000899	CbGpPWpGaD
Ergotamine—HTR1E—Signaling by GPCR—POMC—hypothyroidism	0.000106	0.000898	CbGpPWpGaD
Ergotamine—HTR1B—Signaling by GPCR—AVP—hypothyroidism	0.000106	0.000897	CbGpPWpGaD
Ergotamine—ADRA1D—GPCR downstream signaling—VAV3—hypothyroidism	0.000106	0.000896	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—PRL—hypothyroidism	0.000106	0.000896	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—CLTC—hypothyroidism	0.000105	0.000889	CbGpPWpGaD
Ergotamine—HTR1A—GPCR ligand binding—POMC—hypothyroidism	0.000104	0.000885	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—CLTC—hypothyroidism	0.000104	0.000885	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—TRH—hypothyroidism	0.000104	0.000882	CbGpPWpGaD
Ergotamine—HTR2C—GPCR ligand binding—POMC—hypothyroidism	0.000104	0.00088	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—VAV3—hypothyroidism	0.000104	0.000878	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—VAV3—hypothyroidism	0.000103	0.000875	CbGpPWpGaD
Ergotamine—ADRA1D—GPCR downstream signaling—AVP—hypothyroidism	0.000102	0.000863	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—CLTC—hypothyroidism	9.98e-05	0.000847	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—AVP—hypothyroidism	9.98e-05	0.000846	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—TSHR—hypothyroidism	9.96e-05	0.000845	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—TSHB—hypothyroidism	9.96e-05	0.000845	CbGpPWpGaD
Ergotamine—ADRA1B—GPCR ligand binding—POMC—hypothyroidism	9.93e-05	0.000843	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—AVP—hypothyroidism	9.93e-05	0.000843	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—VAV3—hypothyroidism	9.77e-05	0.000829	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—SH2B3—hypothyroidism	9.65e-05	0.000818	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—ATP5O—hypothyroidism	9.62e-05	0.000816	CbGpPWpGaD
Ergotamine—CYP1A2—Biological oxidations—POMC—hypothyroidism	9.59e-05	0.000814	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—VAV3—hypothyroidism	9.59e-05	0.000814	CbGpPWpGaD
Ergotamine—ADRA2B—GPCR downstream signaling—VAV3—hypothyroidism	9.54e-05	0.000809	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—SH2B3—hypothyroidism	9.45e-05	0.000801	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—AVP—hypothyroidism	9.41e-05	0.000798	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—TRH—hypothyroidism	9.38e-05	0.000796	CbGpPWpGaD
Ergotamine—ADRA2B—Hemostasis—IGF1—hypothyroidism	9.29e-05	0.000788	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—TSHB—hypothyroidism	9.26e-05	0.000786	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—TSHR—hypothyroidism	9.26e-05	0.000786	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—AVP—hypothyroidism	9.24e-05	0.000784	CbGpPWpGaD
Ergotamine—HTR1A—GPCR downstream signaling—VAV3—hypothyroidism	9.21e-05	0.000781	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—CLTC—hypothyroidism	9.2e-05	0.000781	CbGpPWpGaD
Ergotamine—ADRA2B—GPCR downstream signaling—AVP—hypothyroidism	9.19e-05	0.00078	CbGpPWpGaD
Ergotamine—HTR2C—GPCR downstream signaling—VAV3—hypothyroidism	9.16e-05	0.000777	CbGpPWpGaD
Ergotamine—DRD2—GPCR ligand binding—POMC—hypothyroidism	9.16e-05	0.000777	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—TRH—hypothyroidism	9.06e-05	0.000768	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—CLTC—hypothyroidism	9.05e-05	0.000768	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—TPO—hypothyroidism	9.05e-05	0.000768	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—TRH—hypothyroidism	9.01e-05	0.000764	CbGpPWpGaD
Ergotamine—HTR2A—GPCR ligand binding—POMC—hypothyroidism	9.01e-05	0.000764	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—SH2B3—hypothyroidism	8.87e-05	0.000753	CbGpPWpGaD
Ergotamine—HTR1A—GPCR downstream signaling—AVP—hypothyroidism	8.87e-05	0.000752	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—CLTC—hypothyroidism	8.87e-05	0.000752	CbGpPWpGaD
Ergotamine—HTR2C—GPCR downstream signaling—AVP—hypothyroidism	8.82e-05	0.000749	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR ligand binding—POMC—hypothyroidism	8.82e-05	0.000749	CbGpPWpGaD
Ergotamine—ADRA1B—GPCR downstream signaling—VAV3—hypothyroidism	8.77e-05	0.000744	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—IYD—hypothyroidism	8.74e-05	0.000741	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—VAV3—hypothyroidism	8.66e-05	0.000735	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—TRH—hypothyroidism	8.63e-05	0.000732	CbGpPWpGaD
Ergotamine—ADRA1B—GPCR downstream signaling—AVP—hypothyroidism	8.45e-05	0.000717	CbGpPWpGaD
Ergotamine—ABCB1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	8.39e-05	0.000712	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	8.38e-05	0.000711	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—TSHR—hypothyroidism	8.36e-05	0.00071	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—TSHB—hypothyroidism	8.36e-05	0.00071	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—VAV3—hypothyroidism	8.36e-05	0.000709	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—AVP—hypothyroidism	8.34e-05	0.000708	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—VAV3—hypothyroidism	8.32e-05	0.000706	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—SH2B3—hypothyroidism	8.26e-05	0.0007	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CLTC—hypothyroidism	8.24e-05	0.000699	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR ligand binding—POMC—hypothyroidism	8.2e-05	0.000695	CbGpPWpGaD
Ergotamine—DRD2—GPCR downstream signaling—VAV3—hypothyroidism	8.08e-05	0.000686	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—TSHR—hypothyroidism	8.07e-05	0.000685	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—TSHB—hypothyroidism	8.07e-05	0.000685	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—AVP—hypothyroidism	8.05e-05	0.000683	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—TSHB—hypothyroidism	8.03e-05	0.000681	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—TSHR—hypothyroidism	8.03e-05	0.000681	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—AVP—hypothyroidism	8.01e-05	0.00068	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—VAV3—hypothyroidism	7.96e-05	0.000675	CbGpPWpGaD
Ergotamine—HTR2A—GPCR downstream signaling—VAV3—hypothyroidism	7.95e-05	0.000675	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—TRH—hypothyroidism	7.95e-05	0.000675	CbGpPWpGaD
Ergotamine—HTR1D—GPCR downstream signaling—POMC—hypothyroidism	7.9e-05	0.00067	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—TRH—hypothyroidism	7.83e-05	0.000664	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR downstream signaling—VAV3—hypothyroidism	7.79e-05	0.000661	CbGpPWpGaD
Ergotamine—DRD2—GPCR downstream signaling—AVP—hypothyroidism	7.79e-05	0.000661	CbGpPWpGaD
Ergotamine—HTR1B—GPCR downstream signaling—POMC—hypothyroidism	7.74e-05	0.000656	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—TSHB—hypothyroidism	7.69e-05	0.000652	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—TSHR—hypothyroidism	7.69e-05	0.000652	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—AVP—hypothyroidism	7.67e-05	0.000651	CbGpPWpGaD
Ergotamine—HTR2A—GPCR downstream signaling—AVP—hypothyroidism	7.66e-05	0.00065	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—TRH—hypothyroidism	7.66e-05	0.00065	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—TSHB—hypothyroidism	7.59e-05	0.000644	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR downstream signaling—AVP—hypothyroidism	7.5e-05	0.000637	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—SH2B3—hypothyroidism	7.45e-05	0.000632	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—ATP5O—hypothyroidism	7.43e-05	0.00063	CbGpPWpGaD
Ergotamine—CYP3A4—Biological oxidations—POMC—hypothyroidism	7.4e-05	0.000628	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—VAV3—hypothyroidism	7.34e-05	0.000623	CbGpPWpGaD
Ergotamine—HTR2B—GPCR downstream signaling—POMC—hypothyroidism	7.27e-05	0.000617	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—VAV3—hypothyroidism	7.24e-05	0.000614	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—VAV3—hypothyroidism	7.22e-05	0.000613	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—SH2B3—hypothyroidism	7.2e-05	0.00061	CbGpPWpGaD
Ergotamine—HTR1D—Signaling by GPCR—POMC—hypothyroidism	7.18e-05	0.000609	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—SH2B3—hypothyroidism	7.16e-05	0.000607	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—PRL—hypothyroidism	7.16e-05	0.000607	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—TRH—hypothyroidism	7.12e-05	0.000604	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—TSHB—hypothyroidism	7.09e-05	0.000601	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—TSHR—hypothyroidism	7.09e-05	0.000601	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—VAV3—hypothyroidism	7.07e-05	0.0006	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—AVP—hypothyroidism	7.07e-05	0.0006	CbGpPWpGaD
Ergotamine—ADRA2A—Hemostasis—IGF1—hypothyroidism	7.05e-05	0.000598	CbGpPWpGaD
Ergotamine—HTR1B—Signaling by GPCR—POMC—hypothyroidism	7.03e-05	0.000596	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—PRL—hypothyroidism	7.01e-05	0.000595	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—TPO—hypothyroidism	6.98e-05	0.000592	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—TSHR—hypothyroidism	6.97e-05	0.000592	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—TSHB—hypothyroidism	6.97e-05	0.000592	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—AVP—hypothyroidism	6.97e-05	0.000591	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—AVP—hypothyroidism	6.96e-05	0.00059	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—SH2B3—hypothyroidism	6.85e-05	0.000581	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—TSHB—hypothyroidism	6.83e-05	0.000579	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—TSHR—hypothyroidism	6.83e-05	0.000579	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—AVP—hypothyroidism	6.81e-05	0.000578	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—PIK3C2A—hypothyroidism	6.76e-05	0.000574	CbGpPWpGaD
Ergotamine—ADRA1D—GPCR downstream signaling—POMC—hypothyroidism	6.76e-05	0.000574	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—POMC—hypothyroidism	6.63e-05	0.000562	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—VAV3—hypothyroidism	6.62e-05	0.000562	CbGpPWpGaD
Ergotamine—ABCB1—Transmembrane transport of small molecules—AVP—hypothyroidism	6.6e-05	0.00056	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—POMC—hypothyroidism	6.6e-05	0.00056	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—PRL—hypothyroidism	6.58e-05	0.000558	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—VAV3—hypothyroidism	6.57e-05	0.000557	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—VAV3—hypothyroidism	6.48e-05	0.00055	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—AVP—hypothyroidism	6.38e-05	0.000541	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—IGF1—hypothyroidism	6.38e-05	0.000541	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—TSHR—hypothyroidism	6.35e-05	0.000538	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—TSHB—hypothyroidism	6.35e-05	0.000538	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—AVP—hypothyroidism	6.33e-05	0.000537	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—SH2B3—hypothyroidism	6.32e-05	0.000536	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—POMC—hypothyroidism	6.25e-05	0.000531	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—AVP—hypothyroidism	6.25e-05	0.00053	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—SH2B3—hypothyroidism	6.22e-05	0.000527	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—POMC—hypothyroidism	6.14e-05	0.000521	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—PRL—hypothyroidism	6.13e-05	0.00052	CbGpPWpGaD
Ergotamine—ADRA2B—GPCR downstream signaling—POMC—hypothyroidism	6.11e-05	0.000518	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—VAV3—hypothyroidism	6.09e-05	0.000517	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—SH2B3—hypothyroidism	6.09e-05	0.000516	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—IGF1—hypothyroidism	6.01e-05	0.00051	CbGpPWpGaD
Ergotamine—HTR1A—GPCR downstream signaling—POMC—hypothyroidism	5.89e-05	0.0005	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—AVP—hypothyroidism	5.87e-05	0.000498	CbGpPWpGaD
Ergotamine—HTR2C—GPCR downstream signaling—POMC—hypothyroidism	5.86e-05	0.000497	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—SLC5A5—hypothyroidism	5.68e-05	0.000482	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—VAV3—hypothyroidism	5.67e-05	0.000481	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—SH2B3—hypothyroidism	5.66e-05	0.00048	CbGpPWpGaD
Ergotamine—ADRA1B—GPCR downstream signaling—POMC—hypothyroidism	5.61e-05	0.000476	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—POMC—hypothyroidism	5.54e-05	0.00047	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—PRL—hypothyroidism	5.53e-05	0.000469	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—AVP—hypothyroidism	5.46e-05	0.000463	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—POMC—hypothyroidism	5.35e-05	0.000454	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—PRL—hypothyroidism	5.34e-05	0.000453	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—POMC—hypothyroidism	5.33e-05	0.000452	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—PRL—hypothyroidism	5.31e-05	0.000451	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—TSHB—hypothyroidism	5.25e-05	0.000445	CbGpPWpGaD
Ergotamine—DRD2—GPCR downstream signaling—POMC—hypothyroidism	5.18e-05	0.000439	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—VAV3—hypothyroidism	5.12e-05	0.000434	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—POMC—hypothyroidism	5.1e-05	0.000432	CbGpPWpGaD
Ergotamine—HTR2A—GPCR downstream signaling—POMC—hypothyroidism	5.09e-05	0.000432	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—PRL—hypothyroidism	5.08e-05	0.000431	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR downstream signaling—POMC—hypothyroidism	4.99e-05	0.000423	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—VAV3—hypothyroidism	4.94e-05	0.000419	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—AVP—hypothyroidism	4.93e-05	0.000418	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—VAV3—hypothyroidism	4.91e-05	0.000417	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—AVP—hypothyroidism	4.76e-05	0.000404	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—AVP—hypothyroidism	4.73e-05	0.000402	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—VAV3—hypothyroidism	4.7e-05	0.000399	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—POMC—hypothyroidism	4.7e-05	0.000399	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—PRL—hypothyroidism	4.69e-05	0.000398	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—PIK3C2A—hypothyroidism	4.68e-05	0.000397	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—POMC—hypothyroidism	4.63e-05	0.000393	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—POMC—hypothyroidism	4.62e-05	0.000392	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—PRL—hypothyroidism	4.61e-05	0.000391	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—AVP—hypothyroidism	4.53e-05	0.000384	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—POMC—hypothyroidism	4.53e-05	0.000384	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—PRL—hypothyroidism	4.52e-05	0.000383	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—VAV3—hypothyroidism	4.34e-05	0.000368	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—VAV3—hypothyroidism	4.27e-05	0.000362	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—POMC—hypothyroidism	4.24e-05	0.00036	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—POMC—hypothyroidism	4.21e-05	0.000357	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—PRL—hypothyroidism	4.2e-05	0.000356	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—TSHB—hypothyroidism	4.19e-05	0.000355	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—VAV3—hypothyroidism	4.18e-05	0.000354	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—AVP—hypothyroidism	4.18e-05	0.000354	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—POMC—hypothyroidism	4.15e-05	0.000352	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—AVP—hypothyroidism	4.11e-05	0.000349	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—IGF1—hypothyroidism	4.08e-05	0.000346	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—AVP—hypothyroidism	4.02e-05	0.000341	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—IGF1—hypothyroidism	3.99e-05	0.000339	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—SLC5A5—hypothyroidism	3.93e-05	0.000333	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—POMC—hypothyroidism	3.9e-05	0.000331	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—VAV3—hypothyroidism	3.88e-05	0.000329	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—IGF1—hypothyroidism	3.75e-05	0.000318	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—AVP—hypothyroidism	3.74e-05	0.000317	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—PIK3C2A—hypothyroidism	3.73e-05	0.000317	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	3.68e-05	0.000313	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—POMC—hypothyroidism	3.63e-05	0.000308	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—IGF1—hypothyroidism	3.49e-05	0.000296	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—POMC—hypothyroidism	3.28e-05	0.000278	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—TSHB—hypothyroidism	3.23e-05	0.000274	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—POMC—hypothyroidism	3.16e-05	0.000268	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—IGF1—hypothyroidism	3.15e-05	0.000267	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—POMC—hypothyroidism	3.15e-05	0.000267	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—SLC5A5—hypothyroidism	3.14e-05	0.000266	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—IGF1—hypothyroidism	3.04e-05	0.000258	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—IGF1—hypothyroidism	3.03e-05	0.000257	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—POMC—hypothyroidism	3.01e-05	0.000255	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—POMC—hypothyroidism	2.97e-05	0.000252	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—IGF1—hypothyroidism	2.9e-05	0.000246	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	2.88e-05	0.000244	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—POMC—hypothyroidism	2.78e-05	0.000236	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—POMC—hypothyroidism	2.73e-05	0.000232	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—POMC—hypothyroidism	2.67e-05	0.000227	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—IGF1—hypothyroidism	2.67e-05	0.000227	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—IGF1—hypothyroidism	2.63e-05	0.000223	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—IGF1—hypothyroidism	2.57e-05	0.000218	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—POMC—hypothyroidism	2.49e-05	0.000211	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—SLC5A5—hypothyroidism	2.42e-05	0.000205	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—IGF1—hypothyroidism	2.39e-05	0.000203	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—POMC—hypothyroidism	2.06e-05	0.000174	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—POMC—hypothyroidism	1.64e-05	0.000139	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—POMC—hypothyroidism	1.27e-05	0.000107	CbGpPWpGaD
